Fatigue News and Research

RSS

Expressive writing may improve health outcomes for Asian-American breast cancer survivors

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

3 Aug 2014

Acupuncture helps cut fatigue, anxiety and depression in breast cancer patients using aromatase inhibitors

Use of electroacupuncture (EA) - a form of acupuncture where a small electric current is passed between pairs of acupuncture needles - produces significant improvements in fatigue, anxiety and depression in as little as eight weeks for early stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors (AIs) to treat breast cancer.

31 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

Sufferers of Chronic Fatigue Syndrome are set to benefit with the dual launch of a specialist Griffith University clinic and smartphone app, both aimed to manage their illness and improve health outcomes.

29 Jul 2014

Timely diagnosis and treatment important to combat juvenile arthritis

Most people associate arthritis with aging, but the fact is, one in 1,000 children is diagnosed with juvenile arthritis.

27 Jul 2014

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.

26 Jul 2014

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary, today announced that an investigational Phase 3 trial of NEXAVAR (sorafenib) tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival (PFS).

25 Jul 2014

Obese people have low endurance, experience excess fatigue in workplace

Workplaces may need to consider innovative meethods to prevent fatigue from developing in employees who are obese. Based on results from a new study published in the Journal of Occupational and Environmental Hygiene, workers who are obese may have significantly shorter endurance times when perfroming workplace tasks, compared with non-obese counterparts.

24 Jul 2014

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers.

24 Jul 2014

Scientist develops highly accurate device for diagnosing fatal lung disease

A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.

24 Jul 2014

University of Leicester receives funding from two Masonic charities for heart study

A University of Leicester research project has received vital philanthropic funding for the second year from two Masonic charities.

23 Jul 2014

Pilot study shows that anti-cancer drug can activate hidden HIV

A pilot study by HIV researchers from Aarhus University and Aarhus University Hospital in Denmark has shown that an anti-cancer drug can activate hidden HIV.

23 Jul 2014

Parents severely underestimate time children spend on digital devices

According to the American Optometric Association (AOA), parents severely underestimate the time their children spend on digital devices. An AOA survey reports that 83 percent of children between the ages of 10 and 17 estimate they use an electronic device for three or more hours each day.

22 Jul 2014

Chronic fatigue and rheumatoid arthritis: an interview with Ailsa Bosworth, CE, National Rheumatoid Arthritis Society

Chronic fatigue is about much more than merely feeling tired and when it is at its worst, people feel unable to do almost anything, so it can impact absolutely every area of their life.

22 Jul 2014

NuAire's Laminar Airflow Workstations create bacteria-free, clean air environment

NuAire's AireGard ES NU-201 Table Top and NU-301 Console Horizontal Laminar Airflow Hoods provide a HEPA filtered clean work area that is ideal for operations requiring a particle-free, bacteria-free, clean air environment.

22 Jul 2014

NuAire Biosafety Cabinets offer proper ergonomics and improve laboratory safety

NuAire LabGard ES and CellGard ES (Energy Saver) brand of Class II Biological Safety Cabinets offer the proper ergonomics, reduce energy, and improve laboratory safety.

22 Jul 2014

α1-adrenoceptor blockade improves nocturia and sleep quality

Treatment with an α1-adrenoceptor antagonist drug is associated with significant improvements in nocturia, sleep quality and lower urinary tract symptoms in women with voiding symptoms, study findings show.

21 Jul 2014

GSK begins shipment of flu vaccines to U.S. for the upcoming 2014-15 season

GSK announced today it has begun shipping FLUARIX QUADRIVALENT (Influenza Vaccine) doses to U.S. healthcare providers. This is the first shipment of GSK’s U.S. flu vaccine supply for the flu season, following licensing and lot-release approval from the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research.

17 Jul 2014

Rigel initiates Phase 3 clinical program for fostamatinib in patients with ITP

Rigel Pharmaceuticals, Inc. today announced the initiation of a Phase 3 clinical program for its oral SYK inhibitor, fostamatinib, in patients with ITP (immune thrombocytopenic purpura).

16 Jul 2014

Hydroxychloroquine treatment not effective for primary Sjögren syndrome

Among patients with the systemic autoimmune disease primary Sjögren syndrome, use of hydroxychloroquine, the most frequently prescribed treatment for the disorder, did not improve symptoms during 24 weeks of treatment compared with placebo, according to a study in the July 16 issue of JAMA.

16 Jul 2014

Fatigue News and Research

Expressive writing may improve health outcomes for Asian-American breast cancer survivors

Acupuncture helps cut fatigue, anxiety and depression in breast cancer patients using aromatase inhibitors

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

Timely diagnosis and treatment important to combat juvenile arthritis

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Obese people have low endurance, experience excess fatigue in workplace

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Scientist develops highly accurate device for diagnosing fatal lung disease

University of Leicester receives funding from two Masonic charities for heart study

Pilot study shows that anti-cancer drug can activate hidden HIV

Parents severely underestimate time children spend on digital devices

Chronic fatigue and rheumatoid arthritis: an interview with Ailsa Bosworth, CE, National Rheumatoid Arthritis Society

NuAire's Laminar Airflow Workstations create bacteria-free, clean air environment

NuAire Biosafety Cabinets offer proper ergonomics and improve laboratory safety

α1-adrenoceptor blockade improves nocturia and sleep quality

GSK begins shipment of flu vaccines to U.S. for the upcoming 2014-15 season

Rigel initiates Phase 3 clinical program for fostamatinib in patients with ITP

Hydroxychloroquine treatment not effective for primary Sjögren syndrome

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News